论文信息 - Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma. - 字舞流文

Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma.

J. Sarkaria | F. White | J. Eckel-Passow | J. Cochran | N. Agar | P. Decker | C. Giannini | Minjee Kim | S. Stopka | W. Elmquist | I. Parney | Shiv K. Gupta | Jason E. Conage-Pough | M. Regan | B. Marin | G. Kitange | Lihong He | Surabhi Talele | Sonia Jain | B. Carlson | R. Vaubel | Caitlyn L. Miller | Juhee Oh | Ann C. Mladek | K. Bakken | D. Burgenske | Madison H McMinn | Shulan Tian | T. Burns | K. Porath